PRP Injections for Knee Arthritis: The Complete Evidence-Based Guide
- Mar 3
- 8 min read
Written by Dr. Jeffrey Peng, MD — Board-Certified Sports Medicine Physician
Published: March 3, 2025 | Last Updated: March 3, 2025
Platelet-rich plasma (PRP) injections have become one of the most discussed treatments for knee osteoarthritis, yet misinformation remains widespread. Some orthopedic surgeons continue to dismiss PRP as unproven, while certain providers in regenerative medicine make exaggerated claims about regrowing an entirely new knee. The truth, as the latest clinical evidence shows, lies somewhere in between — and it is far more compelling than most patients realize. In this article, I break down the current state of the research on PRP injections for knee arthritis, including platelet dosing, PRP formulations, long-term outcomes, and how PRP compares to stem cell therapies.
Watch the Full Video
What Is Platelet-Rich Plasma (PRP)?
PRP is a treatment that uses a patient's own blood to promote healing and recovery. The procedure involves drawing a sample of blood, placing it in a specialized tube, and spinning it in a centrifuge. This separates the blood into its component layers, allowing us to isolate the fraction richest in platelets and growth factors. That concentrated solution is then injected directly into the knee joint under ultrasound guidance. The goal is to harness your body's own healing biology to decrease pain, reduce inflammation, improve joint lubrication, and protect existing cartilage.
Does PRP Actually Work for Knee Arthritis?
In previous years, there was genuine uncertainty about PRP's effectiveness, as some clinical trials showed positive results while others did not. However, in the last two to three years, this uncertainty has largely resolved. The most recent clinical trials have consistently demonstrated that PRP injections are highly effective for treating symptomatic knee osteoarthritis, making it arguably one of the strongest non-surgical treatment options currently available.
Major orthopedic and sports medicine societies now support PRP for knee arthritis. The American Academy of Orthopaedic Surgeons (AAOS) published a technology overview confirming that PRP injections have been shown to outperform placebo, hyaluronic acid, corticosteroids, exercise and physical therapy, and oral medications (Dubin et al., 2024).
The American Medical Society for Sports Medicine (AMSSM) position statement concludes that PRP injections are more effective than steroid or hyaluronic acid injections for knee osteoarthritis, particularly in younger patients with mild to moderate disease (Finnoff et al., 2021).
European societies have echoed these findings. The European Alliance of Associations of Rheumatology (EULAR) issued clinical practice recommendations stating that PRP is an efficient treatment for early to moderate symptomatic knee osteoarthritis, may be useful in severe disease, and should be proposed as a second-line therapy after failure of non-pharmacological and pharmacological treatments.
Why Platelet Dosing Matters
One of the most critical yet overlooked aspects of PRP treatment is dosing. Just as with any medication used for blood pressure or diabetes, there is a dose-response curve — and we now have strong clarity on what that curve looks like for PRP.
A systematic review published in Arthroscopy found that studies where PRP did not produce a good outcome had a mean platelet dose of approximately 2 billion platelets, while studies demonstrating excellent outcomes had a mean dose of approximately 5.5 billion platelets (Berrigan et al., 2024). This largely explains why earlier clinical trials — which predominantly used low-dose protocols — failed to show benefit.
Further systematic reviews and meta-analyses have found that even higher doses, reaching 10 billion platelets per injection, result in the most favorable clinical outcomes (Berrigan et al., 2024). This finding has significant practical implications for patients seeking PRP treatment.
How to Ensure You Receive High-Dose PRP
The single most important question to ask your provider is how much blood is being drawn. The more blood drawn, the higher the platelet dose. I recommend aiming for 10 billion platelets per injection, which typically requires a 60 cc blood draw. Many physicians performing PRP injections are still not fully aware of the importance of platelet dosing, so this is a critical conversation to have before your procedure.
The second key factor is the centrifugation method. Single-spin techniques are faster but generally recover fewer platelets. Double-spin centrifugation takes longer but recovers significantly more platelets, producing a higher concentration. When evaluating a PRP provider, the two essential questions to confirm are: (1) Is a 60 cc blood draw being performed? (2) Is a double-spin centrifugation protocol being used?
How Many PRP Injections Do You Need?
The current consensus is that three injections are generally better than one. A randomized controlled trial by Görmeli and colleagues demonstrated that patients who received three PRP injections had significantly better outcomes than those who received a single injection, particularly in early-stage osteoarthritis (Görmeli et al., 2015).
That said, many recent studies show that a single high-dose injection of over 10 billion platelets can produce excellent symptom relief lasting up to one year in patients with mild to moderate osteoarthritis. The unanswered question is how much additional benefit a three-injection series provides over a single high-dose treatment. While the impact on pain and function may be similar, the evidence for disease modification — slowing the actual progression of arthritis — favors multiple injections.
Can PRP Slow Arthritis Progression and Rebuild Cartilage?
This is where the evidence becomes particularly compelling. A large, multi-center randomized controlled trial compared three high-dose PRP injections (administered one week apart) to placebo saline injections. Not only did PRP significantly outperform placebo in pain relief and function, but after five years, the PRP group experienced nearly 50% less arthritis progression as measured by cartilage volume on MRI (Chu et al., 2022). This is the strongest argument for opting for a multi-injection series, as we currently have no other disease-modifying treatments — besides exercise, nutrition, and weight management — that can slow the progression of osteoarthritis.
Emerging data also suggest that PRP may promote some cartilage regeneration. In one study, patients who received three PRP injections at one-month intervals showed improvement in knee cartilage thickness (measured by ultrasound) from 0.92 mm at baseline to 1.01 mm at six months (Pundkar et al., 2024). A separate case report documented the healing of a high-grade cartilage defect (osteochondritis dissecans) following four ultra-high-dose PRP injections using 180 cc blood draws. After three years, follow-up MRI showed the defect had reduced from 2.2 x 1.4 cm to 0.7 x 0.5 cm.
These cartilage regeneration findings should be interpreted with caution, as they require replication in larger trials. However, the potential for cartilage restoration is exciting and highlights benefits that no other currently available treatment can offer. While PRP will not restore your knee to its youthful state, it may slow progression and promote some degree of healing — a meaningful advantage over every other non-surgical option.
PRP vs. Stem Cell Treatments for Knee Arthritis
Stem cell treatments are a frequent topic of patient inquiries, and they remain an area filled with misinformation. In the United States, there are currently three types of commercially available "stem cell" injections: amniotic fluid products, bone marrow aspirate concentrate (BMAC), and adipose-derived stromal vascular fraction (SVF). However, recent research raises serious questions about what these products actually contain.
A study analyzing commercial amniotic fluid products found that mesenchymal stem cells could not be identified in any of the tested products. The few nucleated cells found were mostly dead, leading the authors to conclude that these products should not be considered stem cell therapies (Panero et al., 2019).
Even BMAC and SVF — the two most widely used autologous options — contain very few actual stem cells. A comparative analysis published in Science Advances found that stem cells made up only 0.22% of total cells in BMAC and 1.11% in SVF (Ruoss et al., 2024).
The clinical outcomes data further challenges the value proposition of stem cell treatments. The largest randomized controlled trial to date, published in Nature Medicine, enrolled 440 patients across four treatment arms: BMAC, SVF, umbilical cord product, and corticosteroid injection. At 12 months, none of the three stem cell treatments outperformed one another or the corticosteroid control. MRI scans also showed no significant changes in cartilage or arthritis scores compared to baseline (Mautner et al., 2023).
Given that stem cell injections typically cost $5,000 to $10,000 per treatment while PRP ranges from $700 to $1,000 per injection, the cost-effectiveness disparity is substantial. For the price of a single stem cell treatment, a patient could receive five to ten PRP injections — making PRP the far superior option in terms of both efficacy and value based on current evidence.
The Bottom Line on PRP for Knee Arthritis
The evidence supporting PRP for knee osteoarthritis has strengthened dramatically in recent years. Major orthopedic societies now endorse it, and the research consistently shows it outperforms other injection therapies. The key to optimal outcomes is ensuring adequate platelet dosing — aiming for 10 billion platelets via a 60 cc blood draw with double-spin centrifugation. A series of three injections appears to offer the best potential for both symptom relief and disease modification. Based on current evidence, PRP represents the strongest injection-based treatment for knee arthritis, particularly when compared to the considerably more expensive stem cell alternatives.
If you are considering PRP for your knee, I encourage you to discuss these findings with a qualified sports medicine physician who can evaluate your specific condition and determine whether you are a good candidate. For more information about PRP injections and how they are performed in my clinic, visit my PRP treatment page.
References
1. Dubin J, Leucht P, Murray M, Pezold R; AAOS. Platelet-Rich Plasma (PRP) for Knee Osteoarthritis. J Am Acad Orthop Surg. 2024;32(7):296-301. doi:10.5435/JAAOS-D-23-00957
2. Finnoff JT, Awan TM, Borg-Stein J, et al. AMSSM Position Statement: Principles for the Responsible Use of Regenerative Medicine in Sports Medicine. Clin J Sport Med. 2021;31(6):530-541. doi:10.1097/JSM.0000000000000973
3. Berrigan WA, Bailowitz Z, Park A, et al. A Greater Platelet Dose May Yield Better Clinical Outcomes for PRP in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2024;41(3):809-817.e2. doi:10.1016/j.arthro.2024.03.018
4. Berrigan W, Tao F, Kopcow J, et al. The Effect of Platelet Dose on Outcomes after PRP Injections for Musculoskeletal Conditions: A Systematic Review and Meta-Analysis. Curr Rev Musculoskelet Med. 2024;17(12):570-588. doi:10.1007/s12178-024-09922-x
5. Görmeli G, Görmeli CA, Ataoglu B, et al. Multiple PRP Injections Are More Effective Than Single Injections and Hyaluronic Acid in Knees with Early Osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2017;25(3):958-965. doi:10.1007/s00167-015-3705-6
6. Chu J, Duan W, Yu Z, et al. Intra-articular Injections of PRP Decrease Pain and Improve Functional Outcomes Than Sham Saline in Patients with Knee Osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2022;30(12):4063-4071. doi:10.1007/s00167-022-06887-7
7. Pundkar AG, Shrivastava S, Chandanwale R, et al. Exploring the Efficacy of Biologics in Knee Osteoarthritis: Ultrasound Evaluation of Cartilage Regeneration Effects. Indian J Orthop. 2024;58(8):1009-1015. doi:10.1007/s43465-024-01199-z
8. Panero AJ, Hirahara AM, Andersen WJ, et al. Are Amniotic Fluid Products Stem Cell Therapies? A Study of Amniotic Fluid Preparations for MSCs with Bone Marrow Comparison. Am J Sports Med. 2019;47(5):1230-1235. doi:10.1177/0363546519829034
9. Ruoss S, Nasamran CA, Ball ST, et al. Comparative Single-Cell Transcriptional and Proteomic Atlas of Clinical-Grade Injectable Mesenchymal Source Tissues. Sci Adv. 2024;10(28):eadn2831. doi:10.1126/sciadv.adn2831
10. Mautner K, Gottschalk M, Boden SD, et al. Cell-Based Versus Corticosteroid Injections for Knee Pain in Osteoarthritis: A Randomized Phase 3 Trial. Nat Med. 2023;29(12):3120-3126. doi:10.1038/s41591-023-02632-w
Disclaimer: This article is for educational purposes only and does not substitute for the professional judgment of a qualified healthcare provider. Always consult your physician before starting any new treatment. Dr. Jeffrey Peng and jeffreypengmd.com do not endorse any specific test, procedure, or product mentioned in this article.
Comments